802 reports of this reaction
2.5% of all MECLIZINE HCL 25MG reports
#6 most reported adverse reaction
HEADACHE is the #6 most commonly reported adverse reaction for MECLIZINE HCL 25MG, manufactured by Advanced Rx LLC. There are 802 FDA adverse event reports linking MECLIZINE HCL 25MG to HEADACHE. This represents approximately 2.5% of all 32,433 adverse event reports for this drug.
Patients taking MECLIZINE HCL 25MG who experience headache should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
HEADACHE is a less commonly reported adverse event for MECLIZINE HCL 25MG, but still significant enough to appear in the safety profile.
In addition to headache, the following adverse reactions have been reported for MECLIZINE HCL 25MG:
The following drugs have also been linked to headache in FDA adverse event reports:
HEADACHE has been reported as an adverse event in 802 FDA reports for MECLIZINE HCL 25MG. This does not prove causation, but indicates an association observed in post-market surveillance data.
HEADACHE accounts for approximately 2.5% of all adverse event reports for MECLIZINE HCL 25MG, making it a notable side effect.
If you experience headache while taking MECLIZINE HCL 25MG, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.